Study of radiation therapy for belly or pelvic sarcomas
Part of Cancer clinical trials.
This trial is testing a precise type of radiation therapy (called SBRT) for people with sarcoma in the belly or pelvic area. The goal is to see if this targeted radiation can help shrink or control the tumor before surgery, and it may be an option if you haven't had radiation to that area before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of sarcoma (a type of cancer in connective tissue).
- The sarcoma must be in the abdomen (belly) or pelvis area, and it can be new or returning after treatment.
- The main tumor should be able to be removed with surgery.
- You must be 12 years old or older.
- You should be in generally good health (able to do daily activities without major help).
- You cannot have had prior radiation to the same area, and you must not be currently treating another cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
This Phase 1 study tests an “adaptive” form of focused radiation (SBRT) for cancers that have spread in the abdomen or pelvis. It aims to treat metastatic tumor spots safely while adjusting the plan as needed during treatment.
This trial tests a new way to give radiation therapy for tumors in the belly or pelvis. Doctors will use daily MRI scans to adjust the radiation dose, aiming to better protect nearby organs while still treating the cancer.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
This trial tests if giving a short course of radiation therapy combined with immunotherapy before surgery can improve outcomes for people with soft tissue sarcoma in the belly or pelvis. It is for patients whose tumors are hard to remove completely without this pre-treatment.
Hear when a new Abdominopelvic Sarcomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.